People who use drugs are among the most socially excluded groups in Europe. Qualitative
research on Drug Consumption Rooms (DCRs) has reported various benefits to clients …

In this article the authors offer their perspective on the changes in the Dutch harm reduction
field. From the 1970s to the 1990s, the Netherlands emerged as a leader in harm reduction …

Adam Holland and colleagues reported in their Comment1 that nitazenes could be
exacerbating the crisis in drug-related deaths in the UK. Their Comment reinforces concerns …

In recent years, the use of 2-benzylbenzimidazole opioids ('nitazenes') has increased with
them becoming one of the most prominent synthetic opioid subclasses of novel psychoactive …

Abstract Background and Purpose Fentanyls and nitazenes are μ‐opioid receptor agonists
responsible for a large number of opioid overdose deaths. Here, we determined the potency …

Benzylbenzimidazole derivatives or 'nitazenes' are increasingly present on the recreational
drug market. Here, we report the synthesis and pharmacological characterization of 15 …

Benzylbenzimidazole 'nitazene'opioids are presenting a growing threat to public health.
Although various nitazenes were previously studied, systematic comparisons of the effects of …

Aims This study sought to develop and assess an exploratory model of how demographic
and psychosocial attributes, and drug use or acquisition behaviors interact to affect opioid …

Background Management of opioid withdrawal in hospital settings is crucial to improve
treatment completion and health outcomes among patients who use opioids, such as heroin …

This commentary explores a recent shift in British Columbia's drug policy under a novel drug
“decriminalization” framework. We focus on the province's move toward" recriminalization" …